SCHEMBL23631591

SCHEMBL23631591

O=C(O)CNC(=O)Cn1ccc2ccc(-c3cccc([N+](=O)[O-])c3)cc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NTSR1 P30989 5/20 0.43
▸ ALDH1A1 P00352 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ GLA P06280 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ HDAC2 Q92769 1/20 0.42
▸ MME P08473 1/20 0.42
▸ ACHE P22303 1/20 0.41
▸ BACE1 P56817 1/20 0.41
▸ PGR P06401 3/20 0.41
▸ PKM P14618 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ KRAS P01116 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ POLB P06746 1/20 0.38
▸ GRK6 P43250 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23631580 0.92 NTSR1 (0.51) NTSR1HDAC2MMEACHEBACE1
SCHEMBL23631701 0.88 KRAS (0.46) ALDH1A1KDM4EGLAHPGDTSHR
SCHEMBL23631570 0.85 KDM4E (0.52) NTSR1ALDH1A1KDM4EGLAHPGD
SCHEMBL23631593 0.82 KDM4E (0.49) NTSR1ALDH1A1KDM4EGLAHPGD
SCHEMBL23631588 0.81 KRAS (0.56) NTSR1ALDH1A1HTTKRASKMT2A
SCHEMBL23631661 0.80 KDM4E (0.46) NTSR1ALDH1A1KDM4EGLAHPGD
SCHEMBL23631657 0.79 KDM4E (0.45) NTSR1ALDH1A1KDM4EGLAHPGD
SCHEMBL23631689 0.79 KDM4E (0.45) NTSR1ALDH1A1KDM4EGLAHPGD
SCHEMBL23631577 0.78 CA1 (0.45) NTSR1ALDH1A1KDM4EGLAHPGD
SCHEMBL23631579 0.77 NTSR1 (0.44) NTSR1ALDH1A1KDM4EGLAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210214359-A1 Compounds and Methods for Treating Bacterial Infections UNIV NEW YORK (US) 2021-07-15 — — US claimed
US-20210214359-A1 Compounds and Methods for Treating Bacterial Infections UNIV NEW YORK (US) 2021-07-15 — — US disclosed
US-20210214359-A1 Compounds and Methods for Treating Bacterial Infections UNIV NEW YORK (US) 2021-07-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210214359-A1 Compounds and Methods for Treating Bacterial Infections CBS, MPO, QSOX1 NTSR1 2656/4885ALDH1A1 744/4885KDM4E 2239/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback